Congo Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
Condition:   Malaria Interventions:   Drug: Artesunate-amodiaquine;   Drug: Artemether-lumefantrine Sponsors:   Ministry of Public Health, Democratic Republic of the Congo;   University of Kinshasa;   World Health Organization;   Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2020 Category: Research Source Type: clinical trials